openPR Logo
Press release

Japan Generics Drug Market Outlook 2020 Report

05-07-2018 08:42 AM CET | Health & Medicine

Press release from: Kuick Resarch

“Japan Generics Drug Market Outlook 2020” Report Highlights:

* Introduction to Japanese Generic Drug Market
* Attractiveness of Japanese Generic Market
* Super Generics in Japan
* Japan Healthcare System & Generic Drugs
* Different Parameters for Generic & Branded Drugs
* Comparison of Generic Drugs in US & Japan
* Japan Generics Drug Market Analysis
* Japan Generics Drug Market Future Prospects

Download Report Sample Weblink:

https://www.kuickresearch.com/report-Japan-Generics-Drug-Market-Outlook-2020.php

For Report Sample Contact: neeraj@kuickresearch.com

Table of Contents

1. Introduction to Japan Generic Drug Market

1.1 Reasons for Growth of Japan Generic Market

1.2 Some Misconceptions Related to Generic Drugs in Japan



2. Attractiveness of Japan Generic Market

2.1 Overview of Japan Pharmaceutical Market

2.2 Features of Japan Generic Drugs Market

2.3 Generic Drug Firms in Japan

2.4 Generic Drugs Import in Japan

2.5 Economic Views about Generic Drugs



3. Scenario of Generic Drugs in Japan

3.1 Scenario for Generic Drug Discount Price in Japan

3.2 Different Categories of Pharmaceutical Patent in Japan

3.3 Promotion of Generic Drugs in Japan



4. Super Generics in Japan

4.1 Introduction to Super Generics

4.2 Advantages of Super Generics

4.3 Disadvantages of Super Generics



5. Different Parameters for Generic & Branded Drugs in Japan

5.1 Patent Protection in Japan

5.2 Effect on Japan Healthcare Spending

5.3 Japan Pharmacological Parameters for Generic Drugs

5.4 Difference in Regulatory Requirements

5.5 Utilization of Branded & Generic Drugs in Japan Market



6. Generic Active Pharmaceutical Ingredients in Japan

6.1 Generic Active Pharmaceutical Ingredient Registration

6.2 Regulation for Foreign Companies in Japan

6.3 Manufacturing Capabilities for Generic API



7. Health in Japan & Utilization of Generic Drugs

7.1 Cancer Incidences in Japan

7.2 Increasing Diabetes Incidences in Japan

7.3 Increasing Cerebrovascular Incidences in Japan

7.4 Cardiovascular Diseases Incidences in Japan

7.5 Disease Caused by Pollution in Japan



8. Healthcare System & Generic Drugs in Japan

8.1 Universal Healthcare Coverage

8.2 Price Rise Control

8.3 Quality Control of Generic Drugs

8.4 Access to Generic Market

8.5 Patents Related Issues to Generic Drugs in Japan

8.6 Factors Restricting Uptake of Generic Drugs in Japan



9. Comparison of Generic Drugs in US & Japan

9.1 Regulatory Framework for Generic Drugs

9.2 Market Penetration of Generic Drugs

9.3 Prices of Generic Drugs

9.4 Perception towards Generic Drugs



10. Japan Generic Drugs Market Analysis



11. Japan Generic Market Favorable Factors

11.1 Ageing Population

11.2 Generic Drugs Regulations

11.3 High Technological Capabilities

11.4 Increasing Disease Incidences



12. Japan Generics Market Commercialization Challenges

12.1 Japan Regulatory Environment

12.2 Attitude towards Generic Drugs

12.3 Lower uptake of Generic Drugs

12.4 Conflicting Patent Laws



13. Japan Generic Drugs Market Future Prospects



14. Competitive Landscape

14.1 Actavis

14.2 Eisai

14.3 Fuji Pharma

14.4 GlaxoSmithKline

14.5 Hospira

14.6 Meiji Seika Pharma

14.7 Nichi-Iko Pharmaceutical

14.8 Nipro Pharma

14.9 Pfizer

14.10 Sawai Pharmaceuticals

14.11 Takeda Pharmaceutical

14.12 Towa Pharmaceutical

Figure 1-1: Reasons for Growth of Japan Generic Market

Figure 1-2: Some Steps taken by Japan Regulators to Decrease Drug Prices

Figure 1-3: Some Misconceptions Related to Generic Drugs in Japan

Figure 2-1: Some Considerations while Approaching Japan Generic Market

Figure 3-1: Discount Determination of Generic Drugs in Japan

Figure 3-2: Type of Drug Price Survey in Japan

Figure 4-1: Advantages of Super Generics

Figure 4-2: Disadvantages of Super Generics

Figure 5-1: Economic Benefits of opting Generic Drugs

Figure 5-2: Regulatory Requirement for Generic Drugs in Japan

Figure 5-3: Utilization of Branded and Generic Drugs in Japan Market

Figure 6-1: Requirements for Registration of API

Figure 6-2: Regulation for Foreign Companies in Japan

Figure 6-3: Japan - Manufacturing Capabilities for Generic API

Figure 7-1: Aim of Basic Plan to Promote Cancer Control Programs

Figure 7-2: Estimated Numbers of Cancer Cases in Japan, 2015

Figure 8-1: Position of Generics in Japan Healthcare System

Figure 8-2: Patents Related Issues to Generic Drugs in Japan

Figure 10-1: Japan - Generics Drug Market (US$ & Yen), 2014-2016

Figure 10-2: Japan - Generics Drug Share in Pharmaceutical Market (%), 2014

Figure 11-1: Japan - Generic Drugs Market Drivers

Figure 12-1: Japan - Generics Market Commercialization Challenges

Figure 13-1: Japan - Generics Drug Market (US$ & Yen), 2017-2020

Figure 13-2: Japan - Generics Drug Share of Prescription Drug (%), 2018

Figure 13-3: Japan - Generics Drug Share of Prescription Drug (%), 2020

Figure 13-4: Japan - Generics Drug Share in Pharmaceutical Market (%), 2020



Table 1-1: Some Important Features of Japan

Table 3-1: Listing Period for Various Drugs in Japan

Table 5-1: Difference between Branded and Generic Drugs in Japan

Table 5-2: Regulatory Requirements for Different Drugs in Japan

Table 7-1: Estimated Numbers of Different Cancer Affecting Japan Population, 2015

Table 7-2: Estimated Numbers of Males Affected by Different Type of Cancer in Japan, 2015

Table 7-3: Estimated Numbers of Females Affected by Different Type of Cancer in Japan, 2015

Table 7-4: Issues related with Cerebrovascular Diseases

Table 7-5: Some Important Diseases caused by Pollutants in Japan

Table 9-1: Difference in Regulatory Framework between Japan & US

Kuick Research is a market research and analytics company that provides targeted information for critical decisions at business, product and service levels. We are quick, predictive and known by the recommendations we have made in the past. Our result-oriented research methodology offers understanding of multiple issues in a short period of time and gives us the capability to keep you full with loads of practical ideas. By translating research answers into strategic insight and direction, we not only rate the success potential of your products and/or services, but also help you identify the opportunities for growth in new demographies and find ways to beat competition.

Neeraj Chawla
neeraj@kuickresearch.com
KuicK Research
L29 - L34, First Floor
Block L,Connaught Place
New Delhi-110001
+91-11-47067990

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Japan Generics Drug Market Outlook 2020 Report here

News-ID: 1040937 • Views: 319

More Releases from Kuick Resarch

Global Cell Therapy Market To Surpass US$ 35 Billion By 2026
Global cell therapy market is expected to surpass US$ 35 Billion by 2026 as per recent report “Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026” published by Kuick Research. Increasing investment, gaining research and development activities along with new technological advancement will drive the global cell therapy market. Download Report: https://www.kuickresearch.com/report-global-cell-therapy-market,-clinical-trials,-therapy-price-and-opportunity-insight-2026.php “Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026” Report Highlights: • Global Cell Therapy
Cell Therapy Market Size Growth Cell Therapy Clinical Trials Market Forecast 202 …
Cell therapies are still in the infancy stages of the clinical development and are expected to evolve in the market with a vast number of opportunities in the healthcare industry. In order to form a stable base for process evaluation and development it will be essential to understand the quality of cell based products. With an increasing number of cell therapies and clinical indications being assessed, it is clear that
Global Cell Therapy Market Size Analysis Clinical Trials Growth Forecast 2026
"Global Cell Therapy Market, Clinical Trials, Therapy Price & Opportunity Insight 2026" Report Highlights: • Global Cell Therapy Market Opportunity: More Than US$ 35 Billion by 2026 • Cell Therapy Clinical Trial Insight by Indication, Company & Country • Global Cell Therapy Clinical Pipeline: 767 Cell Therapies • Globally Marketed Cell Therapies: 25 Cell Therapies • Maximum Number of Marketed Cell Therapies In USA: 15 Therapies • Price & Product Insight By Region/Country • Regional Analysis of the Cell Therapy Market Download
CAR T Cell Therapy Changing The Cancer Oncology Drug Market Landscape
" Global CAR T Cell Therapy Market & Clinical Trials Insight 2024" Report Highlights: • CAR T-Cell Therapies Delivery Pipeline & Mechanism of Action • Sales Analysis of CAR - T Cell Therapy • CAR - T Cell Therapy Market Opportunity: US$ 700 Million • CAR-T Cell Therapies Clinical Pipeline by Company, Indication & Phase: 236 Therapies • CAR-T Cell Therapies in Highest Phase: Preclinical • Marketed CAR-T Cell Therapies: 2 ( Yescarta & Kymriah) • Global Market Scenario of

All 5 Releases


More Releases for Japan

Global Car Navigation ECU Market Outlook to 2023 – AW Software (Japan), Contin …
An automotive navigation system is part of the automobile controls or a third party add-on used to find direction in an automobile and the ECU is the core part control it. Car Navigation typically uses a satellite navigation device to get its position data which is then correlated to a position on a road. According to this study, over the next five years the Car Navigation ECU market will register a
Data Lines 2017 Global Market Key Players –Sharp(Japan), Sony(Japan), …
Data Lines Market 2017 The global Data Lines market is valued at XX million USD in 2016 and is expected to reach XX million USD by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Japan plays an important role in global market, with market size of xx million USD in 2016 and will be xx million USD in 2022, with a CAGR of xx%. This report studies
Agrochemicals Market in Japan
ReportsWorldwide has announced the addition of a new report title Japan: Agrochemicals: Market Intelligence (2016-2021) to its growing collection of premium market research reports. The report “Japan: Agrochemicals: Market Intelligence (2016-2021)” provides market intelligence on the different market segments, based on type, active ingredient, formulation, crop, and pest. Market size and forecast (2016-2021) has been provided in terms of both, value (000 USD) and volume (000 KG) in the report. A
Consumer Electronics in Japan
Summary Consumer electronics saw annual retail volume decline throughout the review period. This was linked to consumers’ economic uncertainty, population decline and an ongoing shift towards smartphones as an all-in-one device. Smartphones are increasingly used to go online, communicate, play media, capture images and read e-books, with many consumers thus ceasing to buy a wide range of consumer electronics. 2016 however saw the softest retail volume decline of the review period,
Overseas Trade into Japan
Action Storage Systems is actively seeking distributors overseas in an attempt to grow the business in these difficult economic times. In October this year they have set up a new distributor in Japan for the sale of their eXtreme Plastic Lockers®. Koyo specialise in the sale and manufacture of locker systems from their base in Nagano and were established in 1961. Koyo sell throughout Japan and employ fifty sales
Japan Boosts Stimulus
The Bank of Japan has eased monetary policy by expanding asset purchases in a bid to boost growth, and left interest rates unchanged at between zero and 0.1%. The Bank of Japan has eased monetary policy by expanding asset purchases as the yen's strength and slow progress by European leaders in solving the region's debt crisis cloud the outlook for the country's fragile economy. The Bank of Japan (BOJ) has expanded